DK1898876T3 - Mucoadhæsive xyloglucanholdige fprmuleringer anvendelige i medicinske anordninger og i farmaceutiske former - Google Patents

Mucoadhæsive xyloglucanholdige fprmuleringer anvendelige i medicinske anordninger og i farmaceutiske former

Info

Publication number: DK1898876T3
Authority: DK; Denmark
Prior art keywords: mucoadhesive; medical devices; xyloglucan; pharmaceutical forms; containing formulations
Prior art date: 2005-06-06

Application number

DK06754047T

Other languages

Danish (da)

English (en)

Inventor

Giuseppe Bottoni

Paola Maffei

Annalisa Sforzini

Mascia Federici

Carla Caramella

Silvia Rossi

Giuseppe Claudio Viscomi

Original Assignee

Alfa Wassermann Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-06

Filing date

2006-06-01

Publication date

2009-03-02

2006-06-01 Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa

2009-03-02 Application granted granted Critical

2009-03-02 Publication of DK1898876T3 publication Critical patent/DK1898876T3/da

Links

238000009472 formulation Methods 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
230000003232 mucoadhesive effect Effects 0.000 title abstract 3
229920002000 Xyloglucan Polymers 0.000 title abstract 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
210000004400 mucous membrane Anatomy 0.000 abstract 3
238000013270 controlled release Methods 0.000 abstract 2
239000004902 Softening Agent Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
230000003020 moisturizing effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Otolaryngology (AREA)
Oncology (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Gynecology & Obstetrics (AREA)
Communicable Diseases (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Pulmonology (AREA)
Dispersion Chemistry (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Tropical Medicine & Parasitology (AREA)
Rheumatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Virology (AREA)

DK06754047T 2005-06-06 2006-06-01 Mucoadhæsive xyloglucanholdige fprmuleringer anvendelige i medicinske anordninger og i farmaceutiske former DK1898876T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT000388A ITBO20050388A1 (it)	2005-06-06	2005-06-06	Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
PCT/EP2006/005240 WO2006131262A1 (en)	2005-06-06	2006-06-01	Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
DK1898876T3 true DK1898876T3 (da)	2009-03-02

Family

ID=36954507

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06754047T DK1898876T3 (da)	2005-06-06	2006-06-01	Mucoadhæsive xyloglucanholdige fprmuleringer anvendelige i medicinske anordninger og i farmaceutiske former

Country Status (22)

Country	Link
US (3)	US20090081133A1 (de)
EP (1)	EP1898876B1 (de)
JP (1)	JP5118633B2 (de)
KR (1)	KR101337578B1 (de)
CN (2)	CN102079794B (de)
AT (1)	ATE418324T1 (de)
BR (1)	BRPI0611400B8 (de)
CA (1)	CA2604768C (de)
CY (1)	CY1108875T1 (de)
DE (1)	DE602006004451D1 (de)
DK (1)	DK1898876T3 (de)
ES (1)	ES2318756T3 (de)
IL (1)	IL186655A (de)
IT (1)	ITBO20050388A1 (de)
MX (1)	MX2007015074A (de)
NO (1)	NO338991B1 (de)
PL (1)	PL1898876T3 (de)
PT (1)	PT1898876E (de)
RU (1)	RU2403012C2 (de)
SI (1)	SI1898876T1 (de)
UA (1)	UA90507C2 (de)
WO (1)	WO2006131262A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1698630T1 (sl)	2005-03-03	2015-01-30	Alfa Wassermann S.P.A.	Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
US20090068122A1 (en) *	2007-09-06	2009-03-12	Shira Pilch	Dentifrice Compositions for Treating Xerostomia
EA201071166A1 (ru) *	2008-04-11	2011-06-30	Сембайосиз Джинетикс, Инк.	Контролируемое высвобождение активных агентов из олеосом
US8691286B2 (en) *	2009-01-27	2014-04-08	Teleflex Medical Incorporated	Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
JP2011001317A (ja) *	2009-06-19	2011-01-06	Fumakilla Ltd	鼻用洗浄剤
IT1397132B1 (it) *	2009-12-01	2013-01-04	Alfa Wassermann Spa	Composizioni comprendenti antiinfiammatori non steroidei.
AU2011257388B2 (en)	2010-05-24	2016-10-13	Indena S.P.A.	Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
WO2011147767A1 (en)	2010-05-24	2011-12-01	Indena S.P.A.	Tamarind seed polysaccharide for use in the treatment of microbial infections
US9220675B2 (en)	2010-09-09	2015-12-29	Mary Kay Inc.	Topical skin care formulations comprising plant extracts
RS62297B1 (sr)	2011-11-23	2021-09-30	Therapeuticsmd Inc	Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US9091622B2 (en)	2011-12-20	2015-07-28	Exxonmobil Upstream Research Company	Capillary-based calibration standards for measurement of permeability
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
WO2014042875A1 (en)	2012-09-12	2014-03-20	Boston Scientific Scimed, Inc.	Adhesive stent coating for anti-migration
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
ITMI20130960A1 (it) *	2013-06-11	2014-12-12	Novintethical Pharma Sagl	Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
US20150094266A1 (en) *	2013-06-11	2015-04-02	Novintethical Pharma, SA	Xyloglucan and protein compositions for the treatment of intestinal disorders
ITMI20132103A1 (it) *	2013-12-16	2015-06-17	Novintethical Pharma Sagl	Composizioni topiche nasali contenenti xiloglucani per uso come decongestionanti
ES2675305T3 (es) *	2014-04-15	2018-07-10	Novintethical Pharma Sa	Composiciones a base de xiloglucano y proteínas para el tratamiento de trastornos intestinales
RU2016143081A (ru)	2014-05-22	2018-06-26	Терапьютиксмд, Инк.	Натуральные комбинированные гормонозаместительные составы и терапии
EP3174542A4 (de)	2014-07-29	2018-01-03	TherapeuticsMD, Inc.	Transdermale creme
US11623008B2 (en) *	2014-08-20	2023-04-11	Professional Compounding Centers Of America	Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3103438B1 (de)	2015-06-11	2018-11-14	Novintethical Pharma SA	Topische nasale zusammensetzungen mit xyloglucanen zur verwendung als abschwellendes mittel
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
US9931349B2 (en)	2016-04-01	2018-04-03	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
CA3023797A1 (en)	2016-05-31	2017-12-07	Novintethical Pharma Sa	Compositions for the treatment of intestinal disorders
CA3025863A1 (en) *	2016-07-08	2018-01-11	Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.	Pharmaceutical composition comprising benzydamine
IT201700108526A1 (it)	2017-09-28	2019-03-28	Alfasigma Spa	Composizioni orali per il trattamento del refluso gastroesofageo.
JP7601802B2 (ja) *	2019-06-21	2024-12-17	アルファシグマソシエタペルアチオニ	キシログルカン及びアルコールを含む、活性成分の制御放出のためのゲル形態の医薬組成物
IT202100010802A1 (it)	2021-05-03	2022-11-03	Alfasigma Spa	Formulazione solida mucoadesiva comprendente probiotici per uso nella prevenzione e nel trattamento di disbiosi orale.
JP7851113B2 (ja) *	2021-12-08	2026-04-24	Ｍｐ五協フード＆ケミカル株式会社	噴霧用組成物
CN114306237A (zh) *	2022-01-06	2022-04-12	江苏爱朋医疗科技股份有限公司	一种鼻腔护理喷雾剂及其制备方法和应用
WO2026078513A1 (en)	2024-10-07	2026-04-16	Labomar S.P.A.	Formulation comprising a mucoadhesive, washout-resistant and film- forming association

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69012955T2 (de) *	1989-10-31	1995-02-09	Columbia Laboratories, Inc., Miami, Fla.	Verfahren zur Feuchthaltung von Gewebe und Mittel dazu.
JPH07289179A (ja) *	1994-04-28	1995-11-07	Dainippon Pharmaceut Co Ltd	米飯用改質剤
US6271001B1 (en) *	1995-03-23	2001-08-07	Bio Polymers Pty. Ltd.	Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications
JP3909095B2 (ja) *	1995-04-11	2007-04-25	大日本住友製薬株式会社	可逆的熱ゲル化剤
IT1283911B1 (it) *	1996-02-05	1998-05-07	Farmigea Spa	Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US6245354B1 (en) *	1996-02-13	2001-06-12	Dainippon Pharmaceutical Co., Ltd.	Drug delivery system using galactoxyloglucan
JPH11152207A (ja) *	1997-11-20	1999-06-08	Shiseido Co Ltd	化粧料
JPH10259142A (ja) *	1997-03-14	1998-09-29	Shiseido Co Ltd	化粧料
ES2252865T3 (es) *	1997-09-26	2006-05-16	Noven Pharmaceuticals, Inc.	Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
TR200402446T4 (tr) *	2001-05-03	2004-12-21	Farmigea S.P.A.	Servik aşınmanın tedavisi için sükralfatın kullanımı.
DE10344126A1 (de) *	2003-09-24	2005-04-21	Henkel Kgaa	Wasserlöslicher Schmelzklebstoff
US20050214230A1 (en) *	2004-03-23	2005-09-29	J. B. Chemicals & Pharmaceuticals Ltd.	Novel stomatological gel

2005
- 2005-06-06 IT IT000388A patent/ITBO20050388A1/it unknown
2006
- 2006-01-06 UA UAA200711344A patent/UA90507C2/uk unknown
- 2006-06-01 DK DK06754047T patent/DK1898876T3/da active
- 2006-06-01 WO PCT/EP2006/005240 patent/WO2006131262A1/en not_active Ceased
- 2006-06-01 SI SI200630188T patent/SI1898876T1/sl unknown
- 2006-06-01 CN CN2010105570198A patent/CN102079794B/zh active Active
- 2006-06-01 CN CN2006800176445A patent/CN101180036B/zh active Active
- 2006-06-01 DE DE602006004451T patent/DE602006004451D1/de active Active
- 2006-06-01 EP EP06754047A patent/EP1898876B1/de active Active
- 2006-06-01 BR BRPI0611400A patent/BRPI0611400B8/pt not_active IP Right Cessation
- 2006-06-01 JP JP2008514019A patent/JP5118633B2/ja active Active
- 2006-06-01 AT AT06754047T patent/ATE418324T1/de active
- 2006-06-01 MX MX2007015074A patent/MX2007015074A/es active IP Right Grant
- 2006-06-01 CA CA2604768A patent/CA2604768C/en active Active
- 2006-06-01 PT PT06754047T patent/PT1898876E/pt unknown
- 2006-06-01 US US11/921,286 patent/US20090081133A1/en not_active Abandoned
- 2006-06-01 RU RU2007143998/15A patent/RU2403012C2/ru active
- 2006-06-01 KR KR1020077028142A patent/KR101337578B1/ko not_active Expired - Fee Related
- 2006-06-01 ES ES06754047T patent/ES2318756T3/es active Active
- 2006-06-01 PL PL06754047T patent/PL1898876T3/pl unknown
2007
- 2007-10-15 IL IL186655A patent/IL186655A/en active IP Right Grant
- 2007-11-26 NO NO20076083A patent/NO338991B1/no not_active IP Right Cessation
2009
- 2009-03-12 CY CY20091100281T patent/CY1108875T1/el unknown
2011
- 2011-10-19 US US13/277,130 patent/US20120088726A1/en not_active Abandoned
2013
- 2013-01-23 US US13/747,889 patent/US20130183325A1/en not_active Abandoned

Also Published As

Publication number	Publication date
IL186655A (en)	2010-12-30
RU2403012C2 (ru)	2010-11-10
EP1898876B1 (de)	2008-12-24
JP5118633B2 (ja)	2013-01-16
ITBO20050388A1 (it)	2006-12-07
BRPI0611400B8 (pt)	2021-05-25
CN101180036B (zh)	2011-07-27
MX2007015074A (es)	2008-01-24
PT1898876E (pt)	2009-03-05
PL1898876T3 (pl)	2009-06-30
BRPI0611400A2 (pt)	2010-09-08
IL186655A0 (en)	2008-01-20
SI1898876T1 (sl)	2009-04-30
BRPI0611400B1 (pt)	2020-04-28
CY1108875T1 (el)	2014-07-02
JP2008542324A (ja)	2008-11-27
BRPI0611400A8 (pt)	2017-12-26
CN102079794A (zh)	2011-06-01
US20130183325A1 (en)	2013-07-18
ATE418324T1 (de)	2009-01-15
EP1898876A1 (de)	2008-03-19
DE602006004451D1 (de)	2009-02-05
KR101337578B1 (ko)	2013-12-09
UA90507C2 (uk)	2010-05-11
ES2318756T3 (es)	2009-05-01
US20120088726A1 (en)	2012-04-12
KR20080016596A (ko)	2008-02-21
RU2007143998A (ru)	2009-07-20
WO2006131262A1 (en)	2006-12-14
US20090081133A1 (en)	2009-03-26
NO338991B1 (no)	2016-11-07
NO20076083L (no)	2007-11-26
CN102079794B (zh)	2012-03-28
CA2604768C (en)	2013-07-30
CA2604768A1 (en)	2006-12-14
CN101180036A (zh)	2008-05-14

Publication	Publication Date	Title
IL186655A0 (en)	2008-01-20	Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations
HRP20030046B1 (hr)	2011-08-31	Farmaceutski pripravci za tretman bolnih, upalnih i ulcerativnih stanja vlažnih epitelnih površina kao što su mukozitis, stomatitis i behcetov sindrom
DE60120648D1 (de)	2006-07-27	Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
NO20064670L (no)	2006-10-16	Galeniske formuleringer av organiske forbindelser
NO20071354L (no)	2007-05-29	anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
MD20070267A (en)	2008-06-30	Gastroresistant pharmaceutical formulation containing rifaximin
PL373276A1 (en)	2005-08-22	Trans-epicutaneous administration form for treating restless leg syndrome
ITMI20030195A1 (it)	2004-08-07	Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
CO6270217A2 (es)	2011-04-20	Formulaciones galenicas de alisquireno y valsartan
CY1108992T1 (el)	2014-07-02	Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
BRPI0111591B8 (pt)	2021-05-25	composto, composição farmacêutica, e, usos de um composto
PT1383752E (pt)	2005-11-30	3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
AU2002231889A1 (en)	2002-08-06	Halogenated composition, method for preparing same and uses thereof
PT1425005E (pt)	2006-09-29	Composicao farmaceutica que compreende lumiracoxib
FI20095606A7 (fi)	2009-07-30	Järjestelmä ja menetelmä alhaisen suspendoituneen kiintoainepitoisuuden omaavan liuoksen tuottamiseksi ja sellaisen liuoksen käyttö
DK1957037T3 (da)	2010-07-19	Farmaceutisk præparat til nasal anvendelse af fentanyl
HUP0301506A2 (hu)	2003-11-28	Gyógyászati készítmények nedves hámfelületek fájdalmas, gyulladásos vagy fekélyes állapotai, így például nyálkahártyagyulladás, szájgyulladás és behcet-tünetcsoport kezelésére
MD3905F1 (en)	2009-05-31	Remedy of durable action in the form of gel for treatment of parodentium affections (variants)
NO20056241L (no)	2005-12-29	Nanopartikler av polyoksyetylenerte derivater
SE0001916D0 (sv)	2000-05-23	Novel formulation
ITMI20020872A1 (it)	2003-10-23	Derivati dell'iperforina loro uso e formulazioni che li contengono
BRPI0414223A (pt)	2006-10-31	uso de extratos de gentiana lutea como um agente antimicrobiano
PT1490049E (pt)	2006-08-31	Citalopram para o tratamento da pre3ssao sanguinia elevada.
ITMI20071051A1 (it)	2008-11-25	Composizione per il trattamento naturale e/o di sintesi, delle patologie infiammatorie batteriche o virali della gola, con presenza di xerostomia.
BR0205625C1 (pt)	2004-10-19	Formulações nasais em gel